{
    "eid": "2-s2.0-85104610241",
    "title": "Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "anticoagulation",
        "COVID-19",
        "meta-analysis",
        "mortality",
        "SARS-CoV-2"
    ],
    "authors": [
        "Chatphatai Moonla",
        "Darintr Sosothikul",
        "Thita Chiasakul",
        "Ponlapat Rojnuckarin",
        "Noppacharn Uaprasert"
    ],
    "citedby-count": 17,
    "ref-count": 80,
    "ref-list": [
        "Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis",
        "Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19",
        "Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study",
        "Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia",
        "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia",
        "Systemic coagulopathy in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis",
        "Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans",
        "Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis",
        "Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis",
        "Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration",
        "Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19",
        "Prevention, diagnosis, and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report",
        "American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients",
        "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy",
        "Anticoagulation, mortality, bleeding, and pathology among patients hospitalized with COVID-19: A single health system study",
        "Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis",
        "Pharmacologic thromboprophylaxis and thrombosis in hospitalized patients with COVID-19: A pooled analysis",
        "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement",
        "Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention",
        "Severe COVID-19",
        "Subcommittee on control of anticoagulation of the Scientific and Standardization committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients",
        "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses",
        "The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials",
        "Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range",
        "Measuring inconsistency in meta-analyses",
        "Bias in meta-analysis detected by a simple, graphical test",
        "Thrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19",
        "Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study",
        "Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors",
        "The association between treatment with heparin and survival in patients with COVID-19",
        "Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis",
        "Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China",
        "Pulmonary embolism or thrombosis in ARDS COVID-19 patients: A French monocenter retrospective study",
        "Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia",
        "Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom",
        "Empiric therapeutic anticoagulation and mortality in critically ill patients with respiratory failure from SARS-CoV-2: A retrospective cohort study",
        "30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study",
        "Thrombotic complications and anticoagulation in COVID-19 pneumonia: A New York City hospital experience",
        "High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study",
        "Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia",
        "High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?",
        "Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis",
        "Clinical characteristics and 28-day mortality of medical patients admitted with COVID-19 to a central London teaching hospital",
        "Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)",
        "High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients",
        "Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019",
        "Risk factors for intracerebral hemorrhage in patients with COVID-19",
        "Incidence of venous thromboembolism in hospitalized patients with COVID-19",
        "Preliminary experience with low molecular weight heparin strategy in COVID-19 patients",
        "Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action",
        "The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with COVID-19: The Padua province experience",
        "Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: A United States cohort study",
        "The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome",
        "Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom",
        "Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience",
        "Increase in COVID-19 inpatient survival following detection of thromboembolic and cytokine storm risk from the point of admission to hospital by a near real time traffic-light system (TraCe-Tic)",
        "Fibrinolysis shutdown correlates to thromboembolic events in severe COVID-19 infection",
        "Thromboelastography profiles of critically ill patients with coronavirus disease 2019",
        "Association of Padua prediction score with in-hospital prognosis in COVID-19 patients",
        "Increased risk of deep vein thrombosis in intensive care unit patients with COVID-19 infections?-Preliminary data",
        "Anticoagulation in hospitalized patients with COVID-19",
        "COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection",
        "Using heparin molecules to manage COVID-2019",
        "Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients",
        "Mortality risk associated with venous thromboembolism: A systematic review and Bayesian meta-analysis",
        "Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis",
        "Tocilizumab in patients hospitalized with COVID-19 pneumonia",
        "Ischemic heart disease pathophysiology paradigms overview: From plaque activation to microvascular dysfunction",
        "The role of cardiologists in the coronavirus disease 2019 pandemic",
        "Heparin-induced thrombocytopenia in critically ill patients",
        "Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis",
        "Heparin-induced thrombocytopenia in severe COVID-19",
        "Heparin induced thrombocytopenia in patients with COVID-19",
        "Anticoagulation outcomes in hospitalized COVID-19 patients: A systematic review and meta-analysis of case-control and cohort studies",
        "The use of therapeutic-dose anticoagulation and its effect on mortality in patients with COVID-19: A systematic review",
        "Bias and causal associations in observational research",
        "Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients",
        "Rivaroxaban for thromboprophylaxis in acutely ill medical patients",
        "Extended thromboprophylaxis with betrixaban in acutely ill medical patients",
        "Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Department of Medicine, Faculty of Medicine, Chulalongkorn University",
        "Information Technology Center, and Research Affairs, Faculty of Medicine, Chulalongkorn University",
        "King Chulalongkorn Memorial Hospital"
    ]
}